Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer

Por Deshpande, Hari A, Gettinger, Scott, Sosa, Julie Ann
Publicado em 2010

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer

Por Degrauwe, Nils, Sosa, Julie Ann, Roman, Sanziana, Deshpande, Hari A.
Publicado em 2012

Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction

Por Flaig, Thomas W., Plets, Melissa, Hussain, Maha H. A., Agarwal, Neeraj, Mitsiades, Nicholas, Deshpande, Hari A., Vaishampayan, Ulka N., Thompson, Ian M.
Publicado no JAMA Oncol (2017)

Sorafenib for Advanced and Refractory Desmoid Tumors

Por Gounder, Mrinal M., Mahoney, Michelle R., Van Tine, Brian A., Ravi, Vinod, Attia, Steven, Deshpande, Hari A., Gupta, Abha A., Milhem, Mohammed M., Conry, Robert M., Movva, Sujana, Pishvaian, Michael J., Riedel, Richard F., Sabagh, Tarek, Tap, William D., Horvat, Natally, Basch, Ethan, Schwartz, Lawrence H., Maki, Robert G., Agaram, Narasimhan P., Lefkowitz, Robert A., Mazaheri, Yousef, Yamashita, Rikiya, Wright, John J., Dueck, Amylou C., Schwartz, Gary K.
Publicado no N Engl J Med (2018)